According to these results, SLC16A3 expression was noted to be strongly linked to the prognosis of diverse types of cancer, moreover, SLC16A3 exhibited remarkable accuracy (AUC > 0.9) in the prediction of BRCA, CHOL, ESCA, GBM, and KIRC. Here, SLC16A3 is linked to cancer.